Hudock, Inc. Organon & Co. Transaction History

Hudock, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 02, 2022	BUY	$23.4 - $34.25 $468 - $685	20 Added 12.35%	182 $4,000
Q2 2022 Aug 02, 2022	BUY	$31.66 - $38.9 $2,596 - $3,189	82 Added 102.5%	162 $5,000
Q4 2021 Jan 19, 2022	SELL	$28.67 - $37.13 $28 - $37	-1 Reduced 1.23%	80 $2,000
Q3 2021 Nov 09, 2021	SELL	$28.63 - $35.64 $3,865 - $4,811	-135 Reduced 62.5%	81 $2,000
Q2 2021 Aug 09, 2021	BUY	$28.45 - $38.0 $6,145 - $8,208	216 New	216 $6,000

794

193M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $4.11B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Hudock, Inc., based on Form 13F filings with the SEC.

Stay updated on Hudock, Inc. with notifications on news.